Importance of time delay in selecting reperfusion therapy;Importancia del factor tiempo en la elección de la terapia de reperfusión

Revista Espanola de Cardiologia

Volumn 60, Issue 8, 2007, Pages 791-793

  Betriu Gibert, Amadeo ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGRAPHY; ANGIOPLASTY; CATHETERIZATION; CORONARY REPERFUSION; EDITORIAL; FIBRINOLYSIS; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; STATISTICAL ANALYSIS; HEART MUSCLE REPERFUSION; NOTE; TIME;

HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; TIME FACTORS;

EID: 34548030954     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1157/13108990     Document Type: Editorial

References (19)

1. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet. 198;1:397-402.
2. ISIS-2. ISIS-2 (Second International Study of Infarct Survival). Collaborative Group. ISIS-2 Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction. Lancet. 1988;13:349-60.
3. Weaver WD, Simes RJ, Betriu A, Grines CL, Zijlstra F, Garcia E, et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA. 1997;278:2093-8.
4. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;361:13-20.
5. Van de Werf F, Ardissino D, Betriu A, Cokkinos DV, Falk E, Fox KAA, et al. The Task Force on the Management of Acute Myocardial Infarction of The European Society of Cardiology. Eur Heart J. 2003;24:28-66.
6. Sidney C, Smith JR, Feldman TE, Hirschfeld JW Jr, Jacobs AK, Kern MJ, et al. A report of the American College of Cardiology/American heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol. 2006;47:216-35.
7. Andersen HR, Nielsen TT, Rasmussen K, Thuesen L, Kelbaek H, Thayssen P, et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med. 2003;349:733-42.
8. Carrillo P, López-Palop R, Pinar E, Lozano I, Saura, Párraga M, et al. Tratamiento del infarto agudo de miocardio con angioplastia primaria in situ frente a transferencia interhospitalaria para su realización: resultados clínicos a corto y largo plazo. Rev Esp Cardiol. 2007;60:801-10.
9. Carrillo P, López-Palop R, Pinar E, Lozano I, Cortés R, Saura D, et al. Proyecto de un plan de accesibilidad al intervencionismo coronario en el infarto agudo de miocardio en la Región de Murcia. Registro APRIMUR. Rev Esp Cardiol. 2002;55:587-96.
10. Cannon CP, Gibson CM, Lambrew CT, Shoultz DA, Levy D, French WJ, et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA. 2000;283: 2941-7.
11. Nallamothu BK, Bates ER, Herrin J, Wang Y, Bradley EH, Krumholz HM, NRMI Investigators. Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis. Circulation. 2005;111:761-7.
12. Curtis JP, Portnay EL, Wang Y, McNamara RL, Herrin J, Bradley EH, et al. The pre-hospital electrocardiogram and time to reperfusion in patients with acute myocardial infarction, 2000-2002: findings from the National Registry of Myocardial Infarction-4. J Am Coll Cardiol. 2006;47:1544-52.
13. Boersma E, Maas AC, Deckers JW, Simoons ML. Early thrombolytic treatment in acute myocardial infarction: reppraisal of the golden hour. Lancet. 1996;348:771-5.
14. De Luca, Suryapranata H, Zijlstra F, Van't Hof AWJ, Jan CA, Hoorntje A, et al. Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty. J Am Coll Cardiol. 2003;42:991-7.
15. Nallamothu K, Bates ER. Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything? Am J Cardiol. 2003;92:824-6.
16. Nallamothu BK, Antman EM, Bates ER. Primary percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: does the choice of fibrinolytic agent impact on the importance of time-to-treatment? Am J Cardiol. 2004;94:772-4.
17. Betriu A, Masotti M. Comparison of mortality rates in acute myocardial infarction treated by percutaneous coronary intervention versus fibrinolysis. Am J Cardiol. 2005;95:100-1.
18. Stenestrand U, Lindbäck J, Wallentin L, for the RIKS-HIA Registry. Long-term Outcome of Primary Percutaneous Coronary Intervention vs Prehospital and In-Hospital Thrombolysis for Patients With St-Elevation myocardial Infarction. JAMA. 2006;296:1749-56.
19. Pinto DS, Kirtane AJ, Nallamothu BK, Murphy SA, Cohen DJ, Laham RJ, et al. Hospital Delays in Reperfusion for ST-Elevation Myocardial Infarction: Implications When Selecting a Reperfusion Strategy Circulation. 2006;114:2019-25c.